Presenting a special chat session with Dr Timothy Meakin, B.Sc., M.D., FRNZCGP from Meracol to discuss Ibsacol, a treatment for IBS D.When: Sunday June 25, 2006 at 8:30pm-9:30pm ESTWhere: http://ibsgroup.org/groupee/chat?cdra=Y&s=500107 (chat room)Format: Question and AnswerWebsite: http://www.ibsacol.com Dr Meakin is in family practice in Auckland, New Zealand. Nine years ago he was invited to trial Meracol, the active ingredient in Ibsacol. Working with a number of his patients, the results impressed him as to the safety and efficacy of Ibsacol as a new alternative treatment to reduce or eliminate the symptoms of IBS D.At his request, Dr Meakin later was appointed a consultant medical director and subsequently he took an interest in the company. He continues informal trials in his New Zealand clinic with Ibsacol and the various Meracol formulations. His appearance on the Chat Room will offer members a chance to benefit from his clinical experience of Ibsacol as a successful treatment for IBS D and its various associated symptoms. Ibsacol customers report new freedom from the worst symptoms of Irritable Bowel Syndrome -- including the urgency and panic of incontinence with diarrhea, the pain and bloating, flatulence, nausea and griping. At lower dose, it is also shown to be effective for constipation.Ibsacol is safe and natural with no side effects. - Made from the purest plant source, Ibsacol contains a patented fatty acid ester compound specifically formulated for IBS and associated symptoms. - Ibsacol is not a drug, it is a safe dietary supplement. - Ibsacol has been developed in New Zealand and safety tested in a major New Zealand hospital. It is manufactured in a licensed pharmaceutical laboratory.